Tag: Oligodendrocytes
Asterias Expands The Indication Exploration Scope For AST-OPC1 Cell Therapy
Asterias Biotherapeutics, Inc. is a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with demyelination and cellular immunotherapies to treat cancer. Asterias is presently focused on advancing three clinical-stage programs which have the potential to...
